Current issues with covariate adjustment in the analysis of data from randomized controlled trials

American Journal of Therapeutics

Volumn 18, Issue 2, 2011, Pages 153-157

  Alemayehu, Demissie ^a  

^a PFIZER INC   (United States)

Author keywords

analysis of covariance; baseline imbalance; prognostic factors; randomization

Indexed keywords

ANALYTIC METHOD; ARTICLE; CLINICAL DECISION MAKING; COVARIANCE; COVARIATE ADJUSTMENT; MEDICAL RESEARCH; PRIORITY JOURNAL; PROPENSITY SCORE; RANDOMIZATION; RELIABILITY; SENSITIVITY ANALYSIS; STUDY DESIGN; VALIDATION PROCESS;

ANALYSIS OF VARIANCE; DATA INTERPRETATION, STATISTICAL; HUMANS; MODELS, STATISTICAL; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RESEARCH DESIGN;

EID: 79953007721     PISSN: 10752765     EISSN: None     Source Type: Journal    
DOI: 10.1097/MJT.0b013e3181b7d228     Document Type: Article

References (30)

1. Fisher RA. Statistical Methods for Research Workers. Edinburgh United Kingdom: Oliver and Boyd; 1932.
2. Cochran WG. Analysis of variance: its nature and use. Biometrics. 1957;13:261-281.
3. Fisher RA, Day B. The comparison of variability in populations having unequal means. An example of the analysis of covariance with multiple dependent and independent variates. Ann Eugenics. 1937;7:333-348.
4. Altman DG. Better reporting of randomised controlled trials: the CONSORT statement, BMJ. 1996;313:570-571. (Pubitemid 26293636)
5. Alman DG, Dore CJ. Randomisation and baseline comparisons in clinical trials. Lancet. 1990;335:149-153. (Pubitemid 20032736)
6. Altman DG. Comparability of randomised groups. Statistician. 1985;34:125-136.
7. Kennedy A, Grant A. Subversion of allocation in a ran-domised controlled trial. Control Clin Trial. 1997;18(Suppl 3): S77-S78.
8. Senn S. Testing for baseline balance in clinical trials. Stat Med. 1994;13:1715-1726. (Pubitemid 24284854)
9. Roberts C, Torgerson DJ. Baseline imbalance in rando-mised controlled trials. BMJ. 1999;319:185.
10. Maxwell SE. Covariate imbalance and conditional size: dependence on model-based adjustments. Stat Med. 1993; 12:101-109. (Pubitemid 23082187)
11. Senn SJ. Covariate imbalance and random allocation in clinical trials. Stat Med. 1989;8:467-475. (Pubitemid 19105894)
12. Permutt T Testing for imbalance of covariates in con-trolled experiments. Stat Med. 1990;9:1455-1462.
13. Kraemer HC, Wilson GT, Fairburn CG, et al. Mediators and moderators of treatment effects in randomized clini-cal trials. Arch Gen Psychiatry. 2002;59:877-883.
14. Lachin JM. Properties of simple randomization in clinical trials. Control Clin Trials. 1988;9:312-326. (Pubitemid 19012637)
15. Taylor MJ. Why covariance? A rationale for using analysis of covariance procedures in randomized studies. J Early Intervention. 1993;17:455-466.
16. Lachin JM. Statistical properties of randomization in clinical trials. Control Clin Trials. 1988;9:289-311. (Pubitemid 19012636)
17. Krause MS, Howard KI. What random assignment does and does not do. J Clin Psychol. 2003;59:751-766 (Pubitemid 36736707)
18. International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH). ICH E9. Statisical principles for clinical trials. London: European Agency for the Evalu-ation of Medicinal Products; 1998 Feb 5.
19. O'Connor CM, Whellan DJ, Lee KL, et al. Efficacy and safety of exercise training in patients with chronic heart failure: HF-ACTION randomized controlled trial. JAMA. 2009;301:1439-1450
20. GISSI-HF investigators. Effect of n-3 polyunsaturated fatty acids in patients with heart failure: results of the GISSI-HFtrial. Expert Rev Cardiovasc Ther. 2009;7:735-748.
21. Begg B. Suspended judgment. Significance tests of covariate imbalance in clinical trials. Control Clin Trials. 1990;11:223-225.
22. Raab GM, Day S, Sales J. How to select covariates to include in the analysis of a clinical trial. Control Clin Trials. 2000;21:330-342. (Pubitemid 30456293)
23. Gail M, Simon R. Testing for qualitative interactions between treatment effects and patient subsets. Biometrics. 1985;41:361-372.
24. Schemper M, Smith TL. Efficient evaluation of treatment effects in the presence of missing covariate values. Stat Med. 2006;9:777-784.
25. Stefanski LA. Measurement error models. JASA. 2000;95: 1353-1358.
26. Hastie T, Sleeper L, Tibshirani R. Flexible covariate effects in the proportional hazards model. Breast Cancer Res Treat. 1992;22:241-250.
27. Latouche A, Porcher R, Chevret S. A note on including time-dependent covariate in regression model for competing risks data. Biometrical J. 2005;47: 807-814. (Pubitemid 43037332)
28. Sturmer T, Schneeweiss S, Brookhart MA, et al. Analytic strategies to adjust confounding using exposure pro-pensity scores and disease risk scores: nonsteroidal antiinflammatory drugs and short-term mortality in the elderly. Am J Epidemiol. 2005;161:891-898. (Pubitemid 40577844)
29. Kurth T, Walker AM, Glynn RJ, et al. Results of multivariable logistic regression, propensity matching, propensity adjustment, and propensity-based weighting under conditions of nonuniform effect. Am J Epidemiol. 2006;163:262-270. (Pubitemid 43145754)
30. CPMP, Points to consider on adjustment for baseline covariates (CPMP/EWP/2863/99). Stat Med. 2004;23: 701-709.